- Recent Funding
- Investors
- Belmondo
Belmondo portfolio
Belmondo has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Hemotune's $15.52M Series B+ round in March 2024, which it led, alongside Hemex, OCCIDENT, Zürcher Kantonal Bank and 2 others. That company is in Health and bio.
What Belmondo invests in
- Health and bio · 1 · 100%
How Belmondo invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $15.52M |
Belmondo portfolio companies
| Company | Round with Belmondo | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $15.52M · lead | $28.66M | Mar 25, 2024 Series B+ |
Most frequent co-investors
ZZürcher Kantonal Bank1 shared round · last Mar 25, 2024
OOCCIDENT1 shared round · last Mar 25, 2024
HHemex1 shared round · last Mar 25, 2024
VVP Venture Partners1 shared round · last Mar 25, 2024
EEFI Lake Geneva Ventures1 shared round · last Mar 25, 2024
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Belmondo. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Belmondo, which is a subset of its real portfolio. API: /api/v1/investors/belmondo (get a free API key). More: the most active VC firms and new venture capital funds.